Skip to content

Clinical trials

Phase 3 Venous Thromboembolism trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Venous Thromboembolism Phase: Phase 3 Country / region: Russia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20088
20091
20121
20131
20143
20151
20171
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi7
Bayer3
Boehringer Ingelheim3
Daiichi Sankyo2
Avexima Diol LLC1
GlaxoSmithKline1
Janssen Research & Development, LLC1
PharmaDiall Ltd.1
Portola Pharmaceuticals1
Rovi Pharmaceuticals Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Venous Thromboembolism21
Venous Thrombosis8
Pulmonary Embolism6
Neoplasms3
Thromboembolism2
Thrombosis2
COVID-191
Hemorrhage1
Hip Fractures1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.